PharmTech LCGC Sciex Webinar 11.10
|Articles|July 28, 2009

Agilent Technologies Inc. Purchases Varian Inc.

Agilent Technologies Inc. (Santa Clara, California) has agreed to purchase Varian, Inc. (Palo Alto, California) for $1.5 billion or $52 per share.

Agilent Technologies Inc. (Santa Clara, California) has agreed to purchase Varian, Inc. (Palo Alto, California) for $1.5 billion or $52 per share. According to Agilent, the acquisition broadens its' applications and solutions offerings in life sciences, environmental, and energy and materials. It also expands the company’s product portfolio into atomic and molecular spectroscopy; establishes a leading position in NMR, imaging, and vacuum technologies; and strengthens its consumables portfolio.

“This acquisition is a major step in Agilent’s transformation into a leading bio-analytical measurement company,” said Bill Sullivan, Agilent’s president and chief executive officer.

The transaction is expected to generate $75 million in annual cost synergies and achieve Agilent’s 20% return on invested capital (ROIC) target within four to five years. The transaction is subject to approval by the shareholders of Varian and will be completed after achieving customary closing conditions and regulatory approvals, which Agilent expects before calendar year-end.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.